» RFA: Postdoctoral Awards (rev. 09/05/14)
» RFA: HTS Supplemental Grant Program
» RFA: Catalyst Awards (rev. 09/04/14)
The mission of the Chicago Biomedical Consortium is to stimulate collaboration among scientists at Northwestern University, the University of Chicago, and the University of Illinois at Chicago that will transform research at the frontiers of biomedicine.
Anti-dicing Nuclease, a New Kid on the Block that Could Help Combat Cancer
Zain Paroo joined the UIC Center for Pharmaceutical Biotechnology in December 2010. He was a recipient of a CBC Junior Investigator Award. Paroo is a senior author on a publication in the November 20, 2014 issue of Cell Reports entitled, “Rescuing dicer Defects via Inhibition of an Anti-dicing Nuclease.” The paper describes a pre-micro-RNA (pre-miRNA) degrading enzyme that competes with pre-miRNA processing by dicer. This pre-miRNA degrading enzyme could represent a novel therapeutic target for restoring miRNA levels in diseases associated with dicer deficiencies such as cancer.
October 31, 2014
Protein Engineering featured at the 12th Annual CBC Symposium
“Protein Engineering: From Computers to Cells to Clinic” was the topic of the 12th Annual CBC Symposium which took place on Friday, October 17, 2014, at the UIC Forum. The symposium provided a thorough overview of the current status, challenges and exciting prospects in the field of protein engineering. Over 220 students, postdoctoral fellows, faculty, staff and research scientists attended the all day event.
September 3, 2014
Chicago Biomedical Consortium: A Three-University Hub of Research
Leslie Mertz, a science writer for IEEE PULSE, wrote an article titled "Chicago Biomedical Consortium: A Three-University Hub of Research". The article was featured in IEEE PULSE on August 18, 2014.
Chicago Biomedical Consortium announces $3 million Infrastructure Initiative
The Chicago Biomedical Consortium (CBC) is announcing a $3 million Infrastructure Initiative to promote investment in high-impact, next-generation scientific equipment at its member universities. The Initiative aims to make modern and powerful tools available to the CBC research community at a time when federal grants for scientific infrastructure are scarce.
Exploratory Workshops: Applications now being accepted
CBC invites faculty members to apply for the Exploratory Workshops Program. Application deadline: 5pm, Friday, December 5, 2014.
(CBC Exploratory Workshops Program Description and RFA)
Today at NU, UChicago & UIC
TODAY is Monday, November 24, 2014
UChicago Department of Chemistry
Professor James Mayer, Washington University
Proton-Coupled Electron Transfer: from Oxygen Electrocatalysis to Nanoparticles
Calling all Healthcare Technology Innovators, Pioneers and Disruptors
MATTER, the soon-to-open healthcare technology innovation hub is now accepting applications for its first members to join the community in early 2015. Collaborate, Connect And Create new products that impact patient lives. Learn more at http://www.matterchicago.com today.
Chicago Synthetic Antibody Pipeline open for business
Supported by a CBC Lever Award, the Chicago Synthetic Antibody Pipeline (CSAP) is now open to the CBC community. CSAP is a high throughput pipeline designed to produce the next generation of affinity reagents: customized synthetic antibodies (sABs). CBC researchers can nominate protein antigens as targets for sAB generation using existing technology and/or apply for Pilot Projects that will focus on developing ways to extend the applications of the sAB technology.
December 11, 2014
NU Department of Neurology
4th Annual Les Turner Symposium on ALS and NeuroRepair: Neurons that FIRE Together WIRE Together